Skip to main navigation
Skip to search
Skip to main content
Mayo Clinic Home
Home
Profiles
Departments/Divisions
Grants
Research output
Prizes
Search by expertise, name or affiliation
Current and novel therapeutic options for irritable bowel syndrome management
M. Camilleri
, V. Andresen
Gastroenterology and Hepatology
Research output
:
Contribution to journal
›
Short survey
›
peer-review
44
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Current and novel therapeutic options for irritable bowel syndrome management'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Medicine & Life Sciences
Irritable Bowel Syndrome
100%
Chloride Channel Agonists
83%
Somatostatin Receptors
56%
Adrenergic Agonists
55%
Guanylate Cyclase
54%
Serotonin Plasma Membrane Transport Proteins
54%
Neurotransmitter Receptor
53%
Cholecystokinin
51%
Serotonin Receptors
51%
Cholinergic Antagonists
48%
Melatonin
47%
Probiotics
46%
Gastrointestinal Diseases
46%
Benzodiazepines
44%
Habits
41%
Antidepressive Agents
39%
Abdominal Pain
38%
Opioid Analgesics
38%
Hypersensitivity
35%
Psychology
29%
Anti-Bacterial Agents
28%
Drug Therapy
25%
Brain
21%
Population
17%
Therapeutics
14%